During the past decade, Regina Qu'Appelle Health Region conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 2 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Regina Qu'Appelle Health Region" #1 sponsor was "Saskatchewan Health Authority - Regina Area" with 3 trials, followed by "Ottawa Hospital Research Institute" with 2 trials sponsored, "University of Saskatchewan" with 2 trials sponsored, "Minerva Surgical, Inc." with 1 trials sponsored and "Unity Health Toronto" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Regina Qu'Appelle Health Region" #1 collaborator was "Canadian Foundation for Dietetic Research (CFDR)" with 1 trials as a collaborator, "Canadian Institutes of Health Research (CIHR)" with 1 trials as a collaborator, "Lung Association of Saskatchewan" with 1 trials as a collaborator, "Novartis" with 1 trials as a collaborator and "Saskatchewan Health Authority - Regina Area" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Regina Qu'Appelle Health Region" are "Acute Myocardial Infarction" (1 trials), "Asthma" (1 trials), "Autism Spectrum Disorder" (1 trials), "Behavioural Problem" (1 trials) and "Chronic Kidney Disease" (1 trials). Many other conditions were trialed in "Regina Qu'Appelle Health Region" in a lesser frequency.

Most popular intervention types in "Regina Qu'Appelle Health Region" are "Device" (3 trials), "Drug" (3 trials), "Other" (2 trials), "Procedure" (2 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Aurora Endometrial Ablation" (1 trials), "Bupivicaine" (1 trials), "Clinical Pathway (CPW)" (1 trials), "Dexmedetomidine" (1 trials) and "Dinoprostone" (1 trials). Other intervention names were less common.

The vast majority of trials in "Regina Qu'Appelle Health Region" are 6 trials for "All" genders, 3 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Regina Qu'Appelle Health Region". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 7 completed trials in Regina Qu'Appelle Health Region, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Regina Qu'Appelle Health Region, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 5 trials that are defined as “Not Applicable".